Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP): study protocol of a cluster randomised controlled trial
- PMID: 30404619
- PMCID: PMC6223096
- DOI: 10.1186/s12885-018-4962-9
Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP): study protocol of a cluster randomised controlled trial
Abstract
Background: Health service change is difficult to achieve. One strategy to facilitate such change is the clinical pathway, a guide for clinicians containing a defined set of evidence-based interventions for a specific condition. However, optimal strategies for implementing clinical pathways are not well understood. Building on a strong evidence-base, the Psycho-Oncology Co-operative Research Group (PoCoG) in Australia developed an evidence and consensus-based clinical pathway for screening, assessing and managing cancer-related anxiety and depression (ADAPT CP) and web-based resources to support it - staff training, patient education, cognitive-behavioural therapy and a management system (ADAPT Portal). The ADAPT Portal manages patient screening and prompts staff to follow the recommendations of the ADAPT CP. This study compares the clinical and cost effectiveness of two implementation strategies (varying in resource intensiveness), designed to encourage adherence to the ADAPT CP over a 12-month period.
Methods: This cluster randomised controlled trial will recruit 12 cancer service sites, stratified by size (large versus small), and randomised at site level to a standard (Core) versus supported (Enhanced) implementation strategy. After a 3-month period of site engagement, staff training and site tailoring of the ADAPT CP and Portal, each site will "Go-live", implementing the ADAPT CP for 12 months. During the implementation phase, all eligible patients will be introduced to the ADAPT CP as routine care. Patient participants will be registered on the ADAPT Portal to complete screening for anxiety and depression. Staff will be responsible for responding to prompts to follow the ADAPT CP. The primary outcome will be adherence to the ADAPT CP. Secondary outcomes include staff attitudes to and experiences of following the ADAPT CP, using the ADAPT Portal and being exposed to ADAPT implementation strategies, collected using quantitative and qualitative methods. Data will be collected at T0 (baseline, after site engagement), T1 (6 months post Go-live) and T2 (12 months post Go-live).
Discussion: This will be the first cluster randomised trial to establish optimal levels of implementation effort and associated costs to achieve successful uptake of a clinical pathway within cancer care.
Trial registration: The study was registered prospectively with the ANZCTR on 22/3/2017. Trial ID ACTRN12617000411347.
Keywords: Anxiety and depression; Cancer; Clinical pathways; Cluster randomised controlled trial; Health services; Implementation; Psycho-oncology.
Conflict of interest statement
Authors’ information
Not applicable.
Ethics approval and consent to participate
This research is being conducted in accordance with the Declaration of Helsinki and Ethical Approval for this study has been granted by Sydney Local Health District (RPAH Zone) Human Research Ethics Committee, Protocol X16-0378 HREC/16/RPAH/522. Research Participation Agreement and Governance Approvals have been obtained from individual participating institutions. Protocol amendments will be submitted to to the HREC as required throughout the duration of the study.
Cancer service staff at participating cancer services will be give their consent when invited to complete surveys and participate in interviews. Patients at each site participate in the ADAPT CP as part of routine care (which they are offered and can refuse). Patients provide informed consent to collection of health service usage data from the Medical and Pharmaceutical Benefit Schemes in Australia by the research team.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial.Implement Sci. 2023 May 22;18(1):18. doi: 10.1186/s13012-023-01269-0. Implement Sci. 2023. PMID: 37217928 Free PMC article. Clinical Trial.
-
Acceptability and appropriateness of a clinical pathway for managing anxiety and depression in cancer patients: a mixed methods study of staff perspectives.BMC Health Serv Res. 2021 Nov 17;21(1):1243. doi: 10.1186/s12913-021-07252-z. BMC Health Serv Res. 2021. PMID: 34789239 Free PMC article. Clinical Trial.
-
Staff- and service-level factors associated with organisational readiness to implement a clinical pathway for the identification, assessment, and management of anxiety and depression in adults with cancer.BMC Health Serv Res. 2023 Aug 15;23(1):866. doi: 10.1186/s12913-023-09829-2. BMC Health Serv Res. 2023. PMID: 37582818 Free PMC article. Clinical Trial.
-
Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation.J Clin Oncol. 2014 May 20;32(15):1605-19. doi: 10.1200/JCO.2013.52.4611. Epub 2014 Apr 14. J Clin Oncol. 2014. PMID: 24733793 Free PMC article. Review.
-
Symptom Management in Oncology: Depression and Anxiety.Semin Oncol Nurs. 2022 Feb;38(1):151251. doi: 10.1016/j.soncn.2022.151251. Epub 2022 Feb 24. Semin Oncol Nurs. 2022. PMID: 35219567 Review.
Cited by
-
Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin.BMC Cancer. 2025 Jan 29;25(1):171. doi: 10.1186/s12885-025-13506-4. BMC Cancer. 2025. PMID: 39881222 Free PMC article.
-
The Elusive Search for Success: Defining and Measuring Implementation Outcomes in a Real-World Hospital Trial.Front Public Health. 2019 Oct 18;7:293. doi: 10.3389/fpubh.2019.00293. eCollection 2019. Front Public Health. 2019. PMID: 31681724 Free PMC article.
-
External facilitators' perceptions of internal facilitation skills during implementation of collaborative care for mental health teams: a qualitative analysis informed by the i-PARIHS framework.BMC Health Serv Res. 2020 Mar 4;20(1):165. doi: 10.1186/s12913-020-5011-3. BMC Health Serv Res. 2020. PMID: 32131824 Free PMC article. Clinical Trial.
-
Fidelity and acceptability of implementation strategies developed for adherence to a clinical pathway for screening, assessment and management of anxiety and depression in adults with cancer.Arch Public Health. 2024 May 6;82(1):65. doi: 10.1186/s13690-024-01293-6. Arch Public Health. 2024. PMID: 38711115 Free PMC article.
-
Unmet needs in people with high-grade glioma: defining criteria for stepped care intervention.JNCI Cancer Spectr. 2024 Jul 1;8(4):pkae034. doi: 10.1093/jncics/pkae034. JNCI Cancer Spectr. 2024. PMID: 38730547 Free PMC article.
References
-
- Welfare, AIoHa . Cat. no. AUS 199. Canberra: AIHW; 2016. Australia’s health 2016. Australia’s health series no. 15.
-
- AIHW . Cat. no. AUS 122. Canberra: AIHW; 2010. Australia’s health 2010. Australia’s health no. 12.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous